Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance

Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance

Abstract Background Immune checkpoint inhibitor (ICI) myocarditis is associated with high morbidity and mortality. While endomyocardial biopsy (EMB) is considered a gold standard for diagnosis, the sensitivity of EMB is not well defined. Additionally, the pathological features that correlate with th...

Full description

Bibliographic Details
Main Authors: Jesus Jimenez, Nicolas Kostelecky, Joshua D. Mitchell, Kathleen W. Zhang, Chieh-Yu Lin, Daniel J. Lenihan, Kory J. Lavine
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Cardio-Oncology
Subjects:
Cardio-oncology
Immune checkpoint inhibitors
Myocarditis
Macrophage
Online Access:https://doi.org/10.1186/s40959-023-00166-1

Internet

https://doi.org/10.1186/s40959-023-00166-1

Similar Items